We are monitoring the impact of COVID-19 on Latin America Generic Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2094
Share on
Share on

Latin America Generic Drugs Market Research Report - Segmented By Type, Application, & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2094
Pages: 145

Latin America Generic Drugs Market Size (2021 to 2026)

As per our report, the size of the Latin America Generic drugs market has been calculated at USD 37.14 billion in 2021. It is expected to reach USD 50.67 billion by 2026, growing at a CAGR of 6.41% from 2021 to 2026.

The pharmaceutical industry plays a vital role in the growth of generic drugs. The primary drivers of the Latin American generic drugs market are patent expiration it helps initial developer produce lower-cost generic variants and introduce into the market. Generic drugs are of same quality there may some changes in flavor, size, and color but it acts same as the branded drugs. Dosing, safety, strength, quality, how it operates, how it is taken, and how it should be utilized are all the same as the branded drugs.

People prefer most generic drugs as they are cost-efficient and affordable. In addition, an increase in the rates of rising chronic illness is boosting the sales of generic, advances in the formulation of the drugs, and market players are also driving the market growth.

However, patient preferences and assumptions are less likely to choose generic drugs because they believe generic therapies are inferior to branded treatments. Doctors rarely prescribe generic drugs, and chemists only supply medicines that are written on the prescription. In addition, the FDA’s strict guidelines and rules for the approval, side effects of the drugs due to some variation during formulation, color, or flavor are restraining the market growth. Doctor preference towards brands and their brand loyalty towards the branded drugs. Also, generic drugs are not possible as it takes a long time to expire any patent.

This research report on the Latin America generic drugs market has been segmented and sub-segmented into the following categories:

By Type: 

  • Pure Generic Drugs
  • Branded Generic Drugs

By Application: 

  • The Central Nervous System (CNS)
  • Cardiovascular
  • Dermatology
  • Oncology
  • Respiratory
  • Others

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Based on region, Brazil has the highest CAGR in this region. On the other hand, Mexico is estimated to experience strong growth in the generic drug market in the coming future. Also, it is expected to increase the demand with supportive industry and government initiatives; the market is expected to expand the growth of generic medicine during the forecast period.

KEY MARKET PLAYERS:

Companies playing a noteworthy role in the Latin America generic drugs market profiled in the report are Ranbaxy Laboratories, Ltd, Actavis, Mylan, Inc., Industries, Ltd., Dr. Reddy’s Laboratories, Par Pharmaceutical, Inc., Sandoz International GmbH, Hospira, Inc., Apotex, Inc., Watson Pharmaceuticals, Ltd., Teva Pharmaceutical and others.

1.Introduction          

                1.1 Market Definition 

                1.2 Study Deliverables      

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions    

2. Research Methodology   

                2.1 Introduction       

                2.2 Research Phases   

    2.2.1 Secondary Research           

    2.2.2 Primary Research 

    2.2.3 Econometric Modelling      

    2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary    

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints 

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation      

                5.1 Type      

    5.1.1 Introduction           

    5.1.2 Biosimilars   

    5.1.3 simple generics     

    5.1.4 Super generics      

    5.1.5  Y-o-Y Growth Analysis, By Product  

    5.1.6  Market Attractiveness Analysis, By Product

    5.1.7  Market Share Analysis, By Product  

                5.2 Therapeutic drugs

    5.2.1 Introduction           

    5.2.2 Cardiovascular Products    

    5.2.3 Anti-infective Drugs

    5.2.4 Anti Arthritis Drugs  

    5.2.5 Central Nervous System Drugs       

    5.2.6 Anti Cancer Drugs

    5.2.7 Respiratory System Drugs

    5.2.8 Others      

    5.2.9 Y-o-Y Growth Analysis, By Therapeutic Drugs          

    5.2.10 Market Attractiveness Analysis, By Therapeutic Drugs      

    5.2.11 Market Share Analysis, By Therapeutic Drugs        

6. Geographical Analysis      

                6.1 Introduction       

    6.1.1 Regional Trends    

    6.1.2 Impact Analysis     

    6.1.3 Y-o-Y Growth Analysis        

6.1.3.1 By Geographical Area   

6.1.3.2 By Type     

6.1.3.3 By Therapeutic Drugs    

    6.1.4  Market Attractiveness Analysis     

6.1.4.1 By Geographical Area   

6.1.4.2 By Type     

6.1.4.3 By Therapeutic Drugs    

    6.1.5  Market Share Analysis      

6.1.5.1 By Geographical Area   

6.1.5.2 By type     

6.1.5.3 By Therapeutic Drugs    

                6.2 Brazil

                6.3 Argentina 

                6.4 Mexico

                6.5 Chile

7.Strategic Analysis

                7.1 PESTLE analysis 

    7.1.1 Political     

    7.1.2 Economic 

    7.1.3 Social         

    7.1.4 Technological         

    7.1.5 Legal          

    7.1.6 Environmental       

                7.2 Porter’s Five analysis      

    7.2.1 Bargaining Power of Suppliers        

    7.2.2 Bargaining Power of Consumers    

    7.2.3 Threat of New Entrants     

    7.2.4 Threat of Substitute Products and Services  

    7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis 

                8.1 Ranbaxy Laboratories    

    8.1.1 Overview 

    8.1.2 Product Analysis   

    8.1.3 Financial analysis  

    8.1.4 Recent Developments       

    8.1.5 SWOT analysis       

    8.1.6 Analyst View          

                8.2 Actavis  

                8.3 Mylan, Inc. Industries, Ltd.      

                8.4 Dr. Reddy’s Laboratories   

                8.5 Par Pharmaceutical, Inc.

                8.6 Sandoz International GmbH    

                8.7 Celgene Corporation      

                8.8 Apotex, Inc.       

                8.9 Watson Pharmaceuticals, Ltd.    

                8.10 Teva Pharmaceutical and others. 

9.Competitive Landscape    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis    

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities  

Appendix   

                a) List of Tables    

                b) List of Figures      

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Generic Drugs Market, By Type, From 2021 to 2026 (USD Million)
  2. Latin America Biosimilars Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Simple Generics Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Super Generics Market, By Region, From 2021 to 2026 (USD Million)
  5. Latin America Generic Drugs Market, By Therapeutic Drugs, From 2021 to 2026 (USD Million)
  6. Latin America Cardiovascular Drugs Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Anti-Infective Drugs Market, By Region, From 2021 to 2026 (USD Million)
  8. Latin America Anti-Arthritic Drugs Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Central Nervous system Drugs Market, By Region, From 2021 to 2026 (USD Million)
  10. Latin America Anti-Cancer Drugs Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Respiratory Products Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  13. Brazil Generic Drugs Market, By Type, From 2021 to 2026 (USD Million)
  14. Brazil Generic Drugs Market, By Therapeutic Drugs, From 2021 to 2026 (USD Million)
  15. Argentina Generic Drugs Market, By Type, From 2021 to 2026 (USD Million)
  16. Argentina Generic Drugs Market, By Therapeutic Drugs, From 2021 to 2026 (USD Million)
  17. Mexico Generic Drugs Market, By Type, From 2021 to 2026 (USD Million)
  18. Mexico Generic Drugs Market, By Therapeutic Drugs, From 2021 to 2026 (USD Million)
  19. Rest of Latin America Generic Drugs Market, By Type, From 2021 to 2026 (USD Million)
  20. Rest of Latin America Generic Drugs Market, By Therapeutic Drugs, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample